|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2004-4-19
|
|
pubmed:abstractText |
Our study investigated the influence of recombinant human erythropoietin (rHuEPO) treatment, inducing raised hemoglobin levels in nonanemic mice, on intratumor oxygenation before and during fractionated irradiation. Furthermore, the consequences of rHuEPO administration on tumor response to fractionated radiotherapy (RT) were evaluated.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0360-3016
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
59
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
250-9
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15093922-Animals,
pubmed-meshheading:15093922-Cell Hypoxia,
pubmed-meshheading:15093922-Erythropoietin,
pubmed-meshheading:15093922-Glioma,
pubmed-meshheading:15093922-Hemoglobins,
pubmed-meshheading:15093922-Humans,
pubmed-meshheading:15093922-Mice,
pubmed-meshheading:15093922-Mice, Nude,
pubmed-meshheading:15093922-Oxygen,
pubmed-meshheading:15093922-Radiation Tolerance,
pubmed-meshheading:15093922-Recombinant Proteins,
pubmed-meshheading:15093922-Transplantation, Heterologous
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Erythropoietin-induced reduction of hypoxia before and during fractionated irradiation contributes to improvement of radioresponse in human glioma xenografts.
|
|
pubmed:affiliation |
Laboratoire de Recherche en Oncologie, Centre Alexis Vautrin, Vandoeuvre-lès-Nancy, France.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
